AVH 1.62% $3.03 avita medical inc.

ReCell Go Is Massive, page-68

  1. 2,261 Posts.
    lightbulb Created with Sketch. 323
    PNV sales results just out should bode well for Recell Go going forward with the use over BTM PolyNovo's product, The closer these two companies can get the better for patients and sales and profits for both companies.

    Very much looking forward to the August 9th Quarterly outlook now that Recell Go is live and the mini application for FDA lodgment and soon to be approval.

    AVH needs to boost social media presence, so customers demand the Recell get set on media platforms prior to the Vitiligo TONE studies publication due by end of 4th Quarter 2024 and initiate commercial payor/reimbursement discussions early 2025.

    This Vitiligo market is huge
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.